Carter D. Brooks

794 total citations
27 papers, 457 citations indexed

About

Carter D. Brooks is a scholar working on Pharmacology, Immunology and Allergy and Physiology. According to data from OpenAlex, Carter D. Brooks has authored 27 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 10 papers in Immunology and Allergy and 9 papers in Physiology. Recurrent topics in Carter D. Brooks's work include Allergic Rhinitis and Sensitization (10 papers), Asthma and respiratory diseases (8 papers) and Inflammatory mediators and NSAID effects (7 papers). Carter D. Brooks is often cited by papers focused on Allergic Rhinitis and Sensitization (10 papers), Asthma and respiratory diseases (8 papers) and Inflammatory mediators and NSAID effects (7 papers). Carter D. Brooks collaborates with scholars based in United States and United Kingdom. Carter D. Brooks's co-authors include Steven F. Francom, J Sobota, Kenneth J. Tack, Jon Bruss, Robert Cass, Marie T. Borin, David G. Kaiser, Michael K. Bach, Carl M. Metzler and John R. Brashler and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and The American Journal of Medicine.

In The Last Decade

Carter D. Brooks

26 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carter D. Brooks United States 14 148 141 118 56 52 27 457
Mun Su Chung South Korea 16 110 0.7× 92 0.7× 73 0.6× 201 3.6× 76 1.5× 44 579
Christoph Machleidt Germany 12 55 0.4× 47 0.3× 58 0.5× 32 0.6× 35 0.7× 16 561
Alan K. Kamada United States 13 77 0.5× 523 3.7× 75 0.6× 385 6.9× 67 1.3× 29 883
Caroline C. Horner United States 8 208 1.4× 96 0.7× 124 1.1× 54 1.0× 48 0.9× 12 416
Moo Nahm Yum United States 13 228 1.5× 27 0.2× 11 0.1× 94 1.7× 138 2.7× 19 732
Kerryn L. Simpson New Zealand 10 67 0.5× 51 0.4× 53 0.4× 53 0.9× 66 1.3× 10 571
George Perentesis United States 9 63 0.4× 90 0.6× 78 0.7× 40 0.7× 63 1.2× 21 402
Hailing Yang China 13 18 0.1× 143 1.0× 45 0.4× 92 1.6× 113 2.2× 31 500
Chin‐Chung Lin China 12 84 0.6× 36 0.3× 27 0.2× 25 0.4× 77 1.5× 19 462
Jerry Herron United States 14 50 0.3× 276 2.0× 220 1.9× 149 2.7× 38 0.7× 20 573

Countries citing papers authored by Carter D. Brooks

Since Specialization
Citations

This map shows the geographic impact of Carter D. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carter D. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carter D. Brooks more than expected).

Fields of papers citing papers by Carter D. Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carter D. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carter D. Brooks. The network helps show where Carter D. Brooks may publish in the future.

Co-authorship network of co-authors of Carter D. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Carter D. Brooks. A scholar is included among the top collaborators of Carter D. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carter D. Brooks. Carter D. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cass, Robert, et al.. (2011). Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 55(12). 5874–5880. 60 indexed citations
2.
Kiparsky, Michael, Carter D. Brooks, & Peter H. Gleick. (2006). Do Regional Disparities in Research on Climate and Water Influence Adaptive Capacity?. Climatic Change. 77(3-4). 363–375. 10 indexed citations
3.
Brooks, Carter D., et al.. (2003). Cutaneous Allergic Reactions Induced by Sporting Activities. Sports Medicine. 33(9). 699–708. 15 indexed citations
4.
Brooks, Carter D.. (2001). Sulfasalazine for the management of juvenile rheumatoid arthritis.. PubMed. 28(4). 845–53. 31 indexed citations
5.
Daley‐Yates, Peter T., et al.. (1997). Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone. British Journal of Clinical Pharmacology. 43(6). 593–601. 8 indexed citations
6.
Brooks, Carter D., et al.. (1997). Effect of Systemic Corticoid and Antihistamine Alone or in Combination on Elements of the Response to a Two Dose Nasal Allergen Challenge. American Journal of Rhinology. 11(2). 117–122. 2 indexed citations
7.
Brooks, Carter D., et al.. (1996). Spectrum of Seasonal Allergic Rhinitis Symptom Relief with Topical Corticoid and Oral Antihistamine Given Singly or in Combination. American Journal of Rhinology. 10(3). 193–200. 22 indexed citations
8.
Brooks, Carter D., Andrew O. Stewart, Ali Basha, et al.. (1995). Preparation of (R)-(+)-N-[3-[5-[(4-Fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor.. Journal of Medicinal Chemistry. 38(24). 4768–4775. 32 indexed citations
9.
Brooks, Carter D., et al.. (1993). Oral Methylprednisolone Acetate (Medrol Tablets) for Seasonal Rhinitis: Examination of Dose and Symptom Response. The Journal of Clinical Pharmacology. 33(9). 816–822. 18 indexed citations
10.
Brooks, Carter D., et al.. (1993). Effect of vasoconstrictor pre-treatment on obstruction, secretion and sneezing after nasal challenge with threshold and suprathreshold allergen doses.. PubMed. 31(4). 165–8. 3 indexed citations
11.
Brooks, Carter D., et al.. (1991). Unilaterality of obstruction after acute nasal allergen provocation. Relation of allergen dose, nasal reactivity and the nasal cycle. Clinical & Experimental Allergy. 21(5). 583–587. 8 indexed citations
12.
Brooks, Carter D., et al.. (1990). Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established. Clinical & Experimental Allergy. 20(1). 21–26. 24 indexed citations
13.
Brooks, Carter D., et al.. (1990). Clinical Safety of Flurbiprofen. The Journal of Clinical Pharmacology. 30(4). 342–351. 13 indexed citations
14.
Brooks, Carter D., et al.. (1989). Eicosanoid Products in Nasal Rinses Obtained after Acute and Chronic Allergen Stimulation. American Journal of Rhinology. 3(2). 69–76. 1 indexed citations
15.
Olanoff, Lawrence S., et al.. (1987). Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin.. Journal of Clinical Investigation. 80(3). 890–895. 34 indexed citations
16.
Brooks, Carter D., et al.. (1986). Attenuation of Protection With Repeated Cromolyn Dosing Before Exercise Challenge in Subjects With Asthma. The Journal of Clinical Pharmacology. 26(2). 91–96. 2 indexed citations
17.
Nelson, J A, et al.. (1982). Comparison of lodoxamide and cromolyn pretreatment in exercise-challenged asthmatics. Journal of Allergy and Clinical Immunology. 69(1). 153–153. 6 indexed citations
18.
Brooks, Carter D., et al.. (1982). Effect of H2 blockade in the challenged allergic nose. Journal of Allergy and Clinical Immunology. 70(5). 373–376. 23 indexed citations
19.
Bach, Michael K., et al.. (1979). Slow Reacting Substances: Comparison of Some Properties of Human Lung SRS-A and Two Distinct Fractions from Ionophore-Induced Rat Mononuclear Cell SRS. The Journal of Immunology. 122(1). 160–165. 31 indexed citations
20.
Ruoff, Gary, et al.. (1977). Ibuprofen in Osteoarthritis. Southern Medical Journal. 70(1). 49–52. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mun Su Chung Breakdown of academic impact, for papers by Christoph Machleidt Breakdown of academic impact, for papers by Alan K. Kamada Breakdown of academic impact, for papers by Caroline C. Horner Breakdown of academic impact, for papers by Moo Nahm Yum Breakdown of academic impact, for papers by Kerryn L. Simpson Breakdown of academic impact, for papers by George Perentesis Breakdown of academic impact, for papers by Hailing Yang Breakdown of academic impact, for papers by Chin‐Chung Lin Breakdown of academic impact, for papers by Jerry Herron
Rankless by CCL
2026